JPMorgan Chase & Co. Raises Stock Position in The Clorox Company $CLX

JPMorgan Chase & Co. raised its position in The Clorox Company (NYSE:CLX) by 27.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 928,654 shares of the company’s stock after purchasing an additional 197,330 shares during the quarter. JPMorgan Chase & Co. owned about 0.76% of Clorox worth $114,506,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Center for Financial Planning Inc. acquired a new position in Clorox in the third quarter valued at approximately $25,000. Total Investment Management Inc. acquired a new position in shares of Clorox in the 2nd quarter valued at $25,000. True Wealth Design LLC grew its holdings in shares of Clorox by 1,020.0% during the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 204 shares during the period. NewSquare Capital LLC increased its position in shares of Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after purchasing an additional 193 shares during the last quarter. Finally, Root Financial Partners LLC purchased a new stake in Clorox in the 3rd quarter valued at about $29,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Trending Headlines about Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Zacks raised its FY2028 EPS view to $7.23 and upgraded select quarterly/annual estimates (including Q1 2028 to $1.37 and Q4 2026/2027 increases), signaling modestly better forward earnings visibility that can support the stock.
• Positive Sentiment: Clorox published a consumer research report “Home Care Redefined” that underscores evolving demand for wellness- and convenience-oriented home-care products — a strategic tailwind for branded consumer staples. Home Care Redefined
• Neutral Sentiment: Management presented at the Consumer Analyst Group of New York (CAGNY) conference; slides and prepared remarks provide more detail on strategy, cost actions and growth initiatives — useful for longer-term positioning but not an immediate earnings surprise. CAGNY Slides Transcript
• Negative Sentiment: Zacks trimmed multiple near-term quarterly EPS forecasts (several Q2–Q3 2026/2027 cuts and FY2027 lowered to $6.74), reflecting caution about near-term volume/mix or cost pressure — a potential headwind for sentiment and short-term guidance expectations.
• Negative Sentiment: Wells Fargo issued a “Hold” on CLX (reported as “receives a Hold”), which keeps sell-side sentiment neutral-to-cautious and may limit near-term upside from upgrades. Wells Fargo Hold

Analysts Set New Price Targets

Several research analysts have weighed in on CLX shares. JPMorgan Chase & Co. increased their target price on shares of Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 4th. Morgan Stanley increased their price objective on shares of Clorox from $125.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. Weiss Ratings lowered Clorox from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, February 4th. BNP Paribas Exane upgraded Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. Finally, Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and an average price target of $118.73.

Clorox Stock Up 1.1%

Shares of NYSE CLX opened at $123.51 on Monday. The stock has a market cap of $14.93 billion, a P/E ratio of 20.18, a PEG ratio of 0.61 and a beta of 0.59. The business’s fifty day simple moving average is $109.75 and its 200-day simple moving average is $113.51. The Clorox Company has a 12-month low of $96.66 and a 12-month high of $159.04. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 383.01% and a net margin of 11.17%.Clorox’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter last year, the company earned $1.55 EPS. As a group, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.